Search Results - "Shupien, Sally"
-
1
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency
Published in The New England journal of medicine (27-05-2021)“…Fifty patients in the United States and the United Kingdom underwent HSCT with CD34+ cells transduced with a replication-defective lentivirus bearing ADA . At…”
Get full text
Journal Article -
2
Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency
Published in The Journal of clinical investigation (01-05-2017)“…Autologous hematopoietic stem cell transplantation (HSCT) of gene-modified cells is an alternative to enzyme replacement therapy (ERT) and allogeneic HSCT that…”
Get full text
Journal Article -
3
Long-term outcomes after gene therapy for adenosine deaminase severe combined immune deficiency
Published in Blood (14-10-2021)“…Patients lacking functional adenosine deaminase activity have severe combined immunodeficiency (ADA SCID), which can be treated with ADA enzyme replacement…”
Get full text
Journal Article -
4
β-globin gene transfer to human bone marrow for sickle cell disease
Published in The Journal of clinical investigation (01-08-2013)“…Autologous hematopoietic stem cell gene therapy is an approach to treating sickle cell disease (SCD) patients that may result in lower morbidity than…”
Get full text
Journal Article -
5
Lentiviral Gene Therapy with Autologous Hematopoietic Stem and Progenitor Cells (HSPCs) for the Treatment of Severe Combined Immune Deficiency Due to Adenosine Deaminase Deficiency (ADA-SCID): Results in an Expanded Cohort
Published in Blood (13-11-2019)“…Background: Severe combined immunodeficiency due to adenosine deaminase deficiency (ADA-SCID) is a rare disorder caused by ADA gene mutations, leading to…”
Get full text
Journal Article -
6
[Beta]-globin gene transfer to human bone marrow for sickle cell disease
Published in The Journal of clinical investigation (01-08-2013)“…Autologous hematopoietic stem cell gene therapy is an approach to treating sickle cell disease (SCD) patients that may result in lower morbidity than…”
Get full text
Journal Article -
7
Somatic Gene Therapy for X-Linked Severe Combined Immunodeficiency Using a Self-Inactivating Modified Gammaretroviral Vector Results in An Improved Preclinical Safety Profile and Early Clinical Efficacy in a Human Patient
Published in Blood (18-11-2011)“…Abstract 164▪FN2▪This icon denotes a clinically relevant abstract Somatic gene therapy for X-linked severe combined immunodeficiency (X-SCID) using a MLV-based…”
Get full text
Journal Article -
8
Metformin extended release treatment of adolescent obesity: a 48-week randomized, double-blind, placebo-controlled trial with 48-week follow-up
Published in Archives of pediatrics & adolescent medicine (01-02-2010)“…Metformin has been proffered as a therapy for adolescent obesity, although long-term controlled studies have not been reported. To test the hypothesis that 48…”
Get more information
Journal Article